Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04542057
Status:
COMPLETED
Last Update Posted:
2023-10-16
First Post:
2020-09-01
Brief Title:
A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
Sponsor:
Verona Pharma plc
Organization:
Verona Pharma plc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Chronic Obstructive Pulmonary Disease |
Keywords:
| Name | View |
|---|---|
| COPD | View |